Atomwise leverages artificial intelligence to revolutionize drug discovery and development. The platform uses deep learning to predict molecular behavior and identify promising drug candidates faster and more cost-effectively than traditional methods. Features include virtual screening of millions of compounds, protein-drug interaction prediction, lead optimization, repurposing of existing drugs, and partnership programs with pharmaceutical companies and research institutions. Atomwise has identified potential treatments for diseases including Ebola, multiple sclerosis, and COVID-19, demonstrating the power of AI to accelerate pharmaceutical research and bring life-saving medications to market.
